Skip to main content
FinSpry Logo
FinSpry
JANX logo
JANX
(NASDAQ)
Janux Therapeutics, Inc.
$14.84-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Janux Therapeutics (JANX) Stock Price & Financial Analysis

Janux Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$14.22 - $14.91
52-Week High$35.34
52-Week Low$12.12
Open$14.22
Volume1.30M
Average Volume (3M)1.30M
Market Cap919.59M
Shares Outstanding61.97M
Price to Sales (P/S)50.29
Price to Book (P/B)0.94
EV/EBITDA-6.12
Revenue (TTM)17.88M
Net Income (TTM)-113.63M
EPS (TTM)$-1.83
Profit Margin-635.49%
Operating Margin-881.81%
Return on Equity (ROE)-11.88%
Debt to Equity0.04
50-Day MA$13.71
200-Day MA$20.73
52-Week Change-45.88%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Janux Therapeutics

What is the current stock price for JANX?

As of the latest trading session, JANX stock trades at $14.84. The 52-week range is $12.12–$35.34, with a day range of $14.22–$14.91.

What is the P/E ratio for JANX?

The P/E ratio (Price-to-Earnings) for JANX is shown in the Key Statistics section. This valuation metric helps compare Janux Therapeutics, Inc. to industry peers.

Does JANX pay dividends?

Janux Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for JANX?

Based on 4 analysts, the consensus for JANX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of JANX?

Janux Therapeutics's market capitalization is $919.6M, classifying it as a small-cap company. Janux Therapeutics operates in the Healthcare sector within the Biotechnology industry.